about
Vasculoprotective Effects of 3-Hydroxybenzaldehyde against VSMCs Proliferation and ECs InflammationEarly Transcriptomic Response to LDL and oxLDL in Human Vascular Smooth Muscle CellsEpidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors.Transdifferentiation of human endothelial progenitors into smooth muscle cellsToll-like receptor 7 deficiency protects apolipoprotein E-deficient mice from diet-induced atherosclerosisNutraceutical therapies for atherosclerosis.α-Iso-Cubebene Inhibits PDGF-Induced Vascular Smooth Muscle Cell Proliferation by Suppressing Osteopontin Expression.The Angiotensin-(1-7)/Mas Axis Counteracts Angiotensin II-Dependent and -Independent Pro-inflammatory Signaling in Human Vascular Smooth Muscle CellsGenistein suppresses leptin-induced proliferation and migration of vascular smooth muscle cells and neointima formation.Aortic dissection is associated with reduced polycystin-1 expression, an abnormality that leads to increased ERK phosphorylation in vascular smooth muscle cells.Fingerprint of long non-coding RNA regulated by cyclic mechanical stretch in human aortic smooth muscle cells: implications for hypertension.The role of tumor necrosis factor-like weak inducer of apoptosis in atherosclerosis via its two different receptors.Effects of shear stress on endothelial cells: go with the flow.Vascular Stem/Progenitor Cell Migration Induced by Smooth Muscle Cell-Derived Chemokine (C-C Motif) Ligand 2 and Chemokine (C-X-C motif) Ligand 1 Contributes to Neointima Formation.Glycation of high-density lipoprotein triggers oxidative stress and promotes the proliferation and migration of vascular smooth muscle cells.TWEAK blockade decreases atherosclerotic lesion size and progression through suppression of STAT1 signaling in diabetic mice.Tanshinone IIA suppresses the progression of atherosclerosis by inhibiting the apoptosis of vascular smooth muscle cells and the proliferation and migration of macrophages induced by ox-LDLmiR-379 Inhibits Cell Proliferation, Invasion, and Migration of Vascular Smooth Muscle Cells by Targeting Insulin-Like Factor-1.Association of the rs555172 polymorphism in SENCR long non-coding RNA and atherosclerotic coronary artery disease.Chicoric acid prevents PDGF-BB-induced VSMC dedifferentiation, proliferation and migration by suppressing ROS/NFκB/mTOR/P70S6K signaling cascade.Glycolaldehyde-derived advanced glycation end products (glycol-AGEs)-induced vascular smooth muscle cell dysfunction is regulated by the AGES-receptor (RAGE) axis in endothelium.The apolipoprotein A-I mimetic peptide, D-4F, restrains neointimal formation through heme oxygenase-1 up-regulation.Rubiarbonone C inhibits platelet-derived growth factor-induced proliferation and migration of vascular smooth muscle cells through the focal adhesion kinase, MAPK and STAT3 Tyr705 signalling pathways.Expression status and clinical significance of lncRNA APPAT in the progression of atherosclerosis.Smooth Muscle Cell Fate and Plasticity in Atherosclerosis.H19 knockdown suppresses proliferation and induces apoptosis by regulating miR-148b/WNT/β-catenin in ox-LDL -stimulated vascular smooth muscle cells.Can we make physiological research better?Salvia miltiorrhizaBurge (Danshen): A golden herbal medicine in cardiovascular therapeutics.Folic acid delays development of atherosclerosis in low-density lipoprotein receptor-deficient mice.Anti-apoptotic effects of autophagy via ROS regulation in microtubule-targeted and PDGF-stimulated vascular smooth muscle cells.Vitamin supplementation.SHP2 inhibitor PHPS1 protects against atherosclerosis by inhibiting smooth muscle cell proliferation.Endovascular stent-induced alterations in host artery mechanical environments and their roles in stent restenosis and late thrombosis.Up-regulation of heme oxygenase-1 expression and inhibition of disease-associated features by cannabidiol in vascular smooth muscle cellsPro‑atherogenic activation of A7r5 cells induced by the oxLDL/β2GPI/anti‑β2GPI complex
P2860
Q28550935-EC7A1D9A-3C01-48A1-832E-5A70AA86A35EQ28554645-4D61F6C0-7930-40D8-ACBE-36C276E446C5Q30239897-88C1691F-FC76-4496-A23D-5147C204E1F7Q30716459-36113292-05D1-415D-A797-486012307324Q33678336-CD15DB82-DB70-4DA0-B7B4-A39B7C59755CQ36068816-8E52DDA7-8707-4532-920A-A0BF8BD91873Q36257613-6DE34036-5E4C-4290-88B8-DDEF65C5A465Q37503859-F6FA9387-A839-422E-8CEE-4F1953E7639BQ37662916-C099820A-6119-4222-8C98-C376367D5378Q37738521-78731102-BD30-4F91-AF0D-604E3056ED6BQ38433369-697AF029-BE62-4C31-888A-E725B78C61EDQ38638020-1AF68ADD-78B6-4830-9F33-A46CECC03871Q38849620-6BA88DE9-15B3-45C3-B3EE-6E49D3E54E02Q41109128-B7ECD86E-CCC0-459E-AF01-5FA13CBEE443Q41265501-B29FE001-A499-48F6-BC28-D110A868C425Q41870284-942E2FCD-7DEE-4665-92A9-7B06FB0F92F6Q42084567-7BBD8A18-B64E-4A21-A858-133A075BA65FQ42147279-A1FB7472-CA48-4374-B28D-5AEBDC7A2EA3Q45742448-62099D91-5151-41E4-BFB0-2CB50FCCDC40Q46254229-59F3D2C6-8002-4658-B5A2-823AFC1BE355Q46492594-7562E1A6-4EA2-42AE-9B20-7FD66CD8A12DQ47141307-E359825B-2360-4036-A89A-4B7935EA2043Q47917227-B6748D70-501B-413B-A860-FF0B27707C0DQ49491067-210A2112-D269-4914-A5DB-FF05760FDBB8Q49551883-7411AFF2-8636-404F-9D67-BA0FA4D3E573Q49696729-6394B43E-CDB4-4736-8B97-A1B9633450B6Q50063065-914F9707-9455-40DC-B076-08F04326371BQ52561276-07DC6B0B-843F-48F1-BE6A-80246F2EDFB0Q52640082-9F8D3B8B-CB0D-43FB-8E81-2695F316DF74Q52714642-1760A501-86F3-45E4-A775-9710B8170FB0Q52842384-D875A68F-C11C-4848-8384-C69ECDF0AB6BQ55026601-85B8D57E-8579-42F7-9E05-4124A4126496Q55378837-F5C9B1E4-A910-458C-ABD3-348035249612Q57818333-329F75FC-6CDF-4CAD-A860-9C7EC1546F13Q58802965-1E22036E-C3EE-478C-9378-11196C2F07DC
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Vascular smooth muscle cell in atherosclerosis.
@en
type
label
Vascular smooth muscle cell in atherosclerosis.
@en
prefLabel
Vascular smooth muscle cell in atherosclerosis.
@en
P2093
P2860
P356
P1433
P1476
Vascular smooth muscle cell in atherosclerosis.
@en
P2093
A N Orekhov
D A Chistiakov
Y V Bobryshev
P2860
P356
10.1111/APHA.12466
P577
2015-02-25T00:00:00Z